# Efficacy and Safety of High-Dose Oral 35 kDa Hyaluronan for Aesthetic Improvement

> **NCT07583108** · NA · NOT_YET_RECRUITING · sponsor: **Nakhia Impex LLC** · enrollment: 30 (estimated)

## Conditions studied

- Facial Subcutaneous Fullness
- Subcutaneous Fat Accumulation
- Facial Inflammatory Erythema
- Dull Skin
- Facial Vitality Impairment
- Body Weight Management

## Interventions

- **DEVICE:** High-Dose Oral 35 kDa Hyaluronan (HA35)

## Key facts

- **NCT ID:** NCT07583108
- **Lead sponsor:** Nakhia Impex LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-20
- **Primary completion:** 2026-06-20
- **Final completion:** 2026-07-20
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07583108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07583108, "Efficacy and Safety of High-Dose Oral 35 kDa Hyaluronan for Aesthetic Improvement". Retrieved via AI Analytics 2026-07-23 from https://api.ai-analytics.org/clinical/NCT07583108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*